Rising geopolitical risk and fuel volatility are breaking clinical supply assumptions, forcing new strategies to protect trial timelines, patient access, and product integrity.
- Expanding Clinical Trials In Africa Without Disruption
- Bridging Clinical Operations And Supply Chain: Aligning Execution In High-Stakes Trials
- At The Point Of Review: How Clinical Shipments Are Evaluated In Practice
- The cGMP Reality Of Clinical Supply For Advanced Therapies
- How Exit Strategy Should Shape Clinical Trial Supply Planning
- This Assumption Will Break Your Clinical Trial
- When Clinical Supply Fails, Small Biotech Trials Stall
- Putting Vaccine Supply Resilience To The Test: The Last Mile
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Transforming The Pharma Supply Chain
Start leveraging logistics partners with global end-to-end solutions that can help avoid costly delays, ensure high product quality, and accelerate impactful solutions for patients worldwide.
-
Advantages Of Robotic Aseptic Processing
Examine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
How Life Sciences Leaders Are Preparing For More Curveballs In 2026
Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.
-
Hidden Benefits Of Clinical Forecasting & Supply Planning Solutions
Streamline clinical supply chain management with SmartSignals Supplies, reducing errors and inefficiencies from spreadsheet-based forecasting.
-
CDMO Support: Success In Early-Phase Drug Product Development
As sponsors strive to deliver therapies with increasing efficiency, CDMOs are poised to remain vital, offering specialized expertise, accelerated timelines, cost efficiency, and risk mitigation.
-
Ensuring On-Time Release Of CAR-T Cell Treatment In Spain
Due to the COVID-19 pandemic, and the start of Brexit, a CAR-T cell treatment therapy shipment was offloaded multiple times by the airline, requiring an alternative transport solution.
-
Overcoming Obstacles To Deliver Critical Autologous Cell Therapy
See how teams ensured a seamless route, including on-time customs clearance and delivery of autologous cell therapy, from the U.S. to a manufacturing site in Germany
-
RTSM Manages Clinical IP Dispensation In Schizophrenia Study
Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
-
Top Clinical Research Themes And Trends
We analyzed web traffic, content downloads, social media engagement, webinar attendance, and other metrics to determine the themes that caught your attention and aligned with broader industry trends.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.